Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization.

[1]  R. Pedersen,et al.  Spectral Imaging in Preconception/Preimplantation Genetic Diagnosis of Aneuploidy: Multicolor, Multichromosome Screening of Single Cells , 1998, Journal of Assisted Reproduction and Genetics.

[2]  C. Sawyers.  Rational therapeutic intervention in cancer: kinases as drug targets. , 2002, Current opinion in genetics & development.

[3]  T. Lister,et al.  Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Slovak,et al.  Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization. , 2001, Cancer research.

[5]  L. Y. Matsuoka,et al.  Malignant melanoma: An update , 2001 .

[6]  J. Utikal,et al.  Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases. , 2001, Neoplasia.

[7]  A. McGlynn,et al.  Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML. , 2001, Cancer treatment and research.

[8]  M. Radmacher,et al.  Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. , 2000, Cancer genetics and cytogenetics.

[9]  G. Mann,et al.  CDKN2A mutation and deletion status in thin and thick primary melanoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[11]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[12]  M. Slovak,et al.  Twenty‐four‐color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia , 2000, Genes, chromosomes & cancer.

[13]  C. Morelli,et al.  A human melanoma metastasis‐suppressor locus maps to 6q16.3‐q23 , 2000, International journal of cancer.

[14]  P. N. Rao,et al.  Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation. , 1999, Blood.

[15]  S. Merajver,et al.  A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  J. Yun,et al.  Association of EGFR gene fragments with nuclear matrix proteins in high and low metastatic melanoma cell lines. , 1999, Anticancer research.

[17]  M. Slovak,et al.  Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[19]  F. Mertens,et al.  Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocvtic leukemia (sANLL) , 1991, European journal of haematology.

[20]  R. Berger.  Cytogenetics of secondary acute non-lymphocytic leukemia. , 1987, Haematologica.

[21]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[22]  N. Sampas,et al.  malignant melanoma by gene expression pro ® , 2022 .